Antifibrotic Effect of Tamoxifen in a Model of Progressive Renal Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antifibrotic Effect of Tamoxifen in a Model of Progressive Renal Disease

Published:2011-11-03 Issue:1 Volume:23 Page:37-48
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Dellê Humberto,Rocha José Roberto C.,Cavaglieri Rita C.,Vieira José Mauro,Malheiros Denise M.A.C.,Noronha Irene L.

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference70 articles.

1. The inflammatory component in progressive renal disease—are interventions possible?

2. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.

3. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney

4. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

5. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocyte Growth Factor DNA Aptamer for Prevention of Postoperative Peritoneal Adhesion via Enhancement of Fibrinolysis and Inhibition of Mesothelial Mesenchymal Transition;ACS Applied Bio Materials;2024-07-04

2. Sex Difference in the Association Between Serum Versican and Albuminuria in Patients with Type 2 Diabetes Mellitus;Diabetes, Metabolic Syndrome and Obesity;2023-11

3. Tamoxifen exerts anti-peritoneal fibrosis effects by inhibiting H19-activated VEGFA transcription;Journal of Translational Medicine;2023-09-11

4. Tamoxifen associated to the conservative CKD treatment promoted additional antifibrotic effects on experimental hypertensive nephrosclerosis;Scientific Reports;2023-08-26

5. PFKFB3-Mediated Glycolysis Boosts Fibroblast Activation and Subsequent Kidney Fibrosis;Cells;2023-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3